Not Signed In -
Pancreatic Cancer |
|
|
Pancreatic cancer (also called cancer of the pancreas) is represented by the growth of a malignant tumour within the pancreatic gland. Each year about 32,180 individuals in the United States are diagnosed with this condition, with more than 60,000 in Europe. Depending on the extent at the time of diagnosis, the prognosis is generally regarded as poor, with few victims still alive 5 years after diagnosis, and complete remission still extremely rare. Most pancreatic tumors are adenocarcinomas ...
Wikipedia - [full article]
Pancreatic Cancer Clinical Trials
- 3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00064051 - Active, not recruiting
stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer
- Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00005869 - Active, not recruiting
recurrent pancreatic cancer; stage II pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; ...
- Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00004003 - Active, not recruiting
recurrent pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer
- Gemcitabine With or Without R115777 in Treating Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00005648 - Active, not recruiting
recurrent pancreatic cancer; stage II pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; ...
- Paclitaxel and Bryostatin-1 in Treating Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00031694 - Active, not recruiting
stage II pancreatic cancer; stage III pancreatic cancer; recurrent pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; ...
- Sorafenib and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00095966 - Active, not recruiting
adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
- Phase I Study of Vaccination With MUC-1 Antigen and Immunologic Adjuvant SB AS-2 in Patients With Resected or Locally Advanced Unresectable Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00008099 - Active, not recruiting
stage I pancreatic cancer; stage II pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer
- Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00088894 - Active, not recruiting
adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
- 3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00078975 - Active, not recruiting
adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
- Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00111904 - Recruiting
stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer
- Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00068432 - Active, not recruiting
recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Sorafenib With or Without Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00114244 - Active, not recruiting
recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00003591 - Active, not recruiting
stage III pancreatic cancer; adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage I pancreatic cancer; stage II pancreatic cancer
- Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00005053 - Active, not recruiting
recurrent pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
- Gemcitabine With or Without Pemetrexed Disodium in Treating Patients With Unresectable Stage II, Stage III, or Stage IV Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00049426 - Active, not recruiting
stage II pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; stage IVA pancreatic cancer; adenocarcinoma of the pancreas
- Docetaxel and Gemcitabine Compared With Docetaxel and Cisplatin in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00004884 - Active, not recruiting
recurrent pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
- 3-AP as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma (Cancer) of the Pancreas
ClinicalTrials.gov Identifier: NCT00085371 - Active, not recruiting
adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
- Tipifarnib and Radiation Therapy in Treating Patients With Unresectable Locally Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00077519 - Active, not recruiting
stage II pancreatic cancer; stage III pancreatic cancer; recurrent pancreatic cancer
- BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery
ClinicalTrials.gov Identifier: NCT00024362 - Active, not recruiting
stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
- Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00058149 - Active, not recruiting
stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
- DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00024375 - Active, not recruiting
recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma
ClinicalTrials.gov Identifier: NCT00075452 - Active, not recruiting
adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00003851 - Active, not recruiting
stage II pancreatic cancer; stage III pancreatic cancer; stage IV pancreatic cancer; Nutrition; adenocarcinoma of the pancreas
- Bevacizumab With or Without Docetaxel in Treating Patients With Previously Treated Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00066677 - Active, not recruiting
adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas
ClinicalTrials.gov Identifier: NCT00002955 - Active, not recruiting
stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00030732 - Active, not recruiting
stage III pancreatic cancer; recurrent pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas
ClinicalTrials.gov Identifier: NCT00003780 - Active, not recruiting
stage III pancreatic cancer; stage IV pancreatic cancer; Quality of Life; stage II pancreatic cancer
- Gemcitabine With or Without Erlotinib in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00026338 - Active, not recruiting
stage III pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00010062 - Active, not recruiting
stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer
- Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00100815 - Active, not recruiting
adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer
- Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00023972 - Active, not recruiting
stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00003025 - Active, not recruiting
stage I pancreatic cancer; stage II pancreatic cancer; adenocarcinoma of the pancreas
- Dolastatin 10 in Treating Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00003677 - Active, not recruiting
recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
- Adjuvant Chemoradiotherapy and Interferon alfa in Treating Patients With Resected Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00059826 - Active, not recruiting
stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
- Cisplatin, Metronomic Low-Dose Interferon alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00082862 - Recruiting
stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer
- Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas
ClinicalTrials.gov Identifier: NCT00003797 - Active, not recruiting
recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00323583 - Recruiting
Adenocarincoma of Pancreas; Stage III Pancreatic Cancer; Stage IVA Pancreatic Cancer; Stage IVB Pancreatic Cancer
- Study of the Efficacy and Safety of Glufosfamide Compared with Best Supportive Care in Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00099294 - Active, not recruiting
Pancreatic Cancer
- Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00004861 - Active, not recruiting
stage II pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
- Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct
ClinicalTrials.gov Identifier: NCT00010088 - Active, not recruiting
adenocarcinoma of the extrahepatic bile duct; stage II pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; ...
- Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00003546 - Active, not recruiting
stage III pancreatic cancer; adenocarcinoma of the pancreas; stage I pancreatic cancer; stage II pancreatic cancer
- Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00112528 - Active, not recruiting
duct cell adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer
- R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00005832 - Active, not recruiting
childhood gastrointestinal cancer; stage II pancreatic cancer; stage IVA pancreatic cancer; duct cell adenocarcinoma of the pancreas; ...
- Screening For Early Pancreatic Neoplasia in Individuals With Familial Peutz-Jeghers Syndrome and in Relatives of Individuals With Familial Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00084357 - Active, not recruiting
Pancreatic Cancer
- Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas
ClinicalTrials.gov Identifier: NCT00079365 - Active, not recruiting
adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Flavopiridol Plus Radiation Therapy Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00047307 - Recruiting
adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer
- Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00091026 - Recruiting
adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
- Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00096070 - Active, not recruiting
adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer
- Antineoplaston Therapy in Treating Patients With Stage IV Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00003531 - Recruiting
recurrent pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00112580 - Recruiting
stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer; adenocarcinoma of the pancreas
- Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas
ClinicalTrials.gov Identifier: NCT00003216 - Active, not recruiting
stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer
- Pilot Study Using Neoadj Chemo-Rad & EGFR-Tyrosine Kinase Inhibitor for Potentially Resectable Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00243854 - Recruiting
Pancreatic Cancer
- Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00064207 - Active, not recruiting
adenocarcinoma of the pancreas; stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer
- Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00006117 - Active, not recruiting
stage III pancreatic cancer; stage IV pancreatic cancer; adenocarcinoma of the pancreas
- A Study to Test the Effectiveness of Virulizin® Given in Combination with Standard Chemotherapy for Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00040092 - Active, not recruiting
Pancreatic Cancer
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00026403 - Active, not recruiting
stage III pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer
- Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00003332 - Active, not recruiting
stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
- 6-Hydroxymethylacylfulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00003760 - Active, not recruiting
recurrent pancreatic cancer; stage III pancreatic cancer; stage IV pancreatic cancer; adenocarcinoma of the pancreas
- Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
ClinicalTrials.gov Identifier: NCT00003029 - Active, not recruiting
stage III pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Gemcitabine With or Without Cetuximab as First-Line Therapy in Treating Patients With Locally Advanced Unresectable or Metastatic Adenocarcinoma of the Pancreas
ClinicalTrials.gov Identifier: NCT00075686 - Active, not recruiting
adenocarcinoma of the pancreas; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- ISIS 2503 in Treating Patients With Advanced Cancer of the Pancreas
ClinicalTrials.gov Identifier: NCT00005594 - Active, not recruiting
stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
- Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas
ClinicalTrials.gov Identifier: NCT00003049 - Active, not recruiting
stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
- Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00049348 - Active, not recruiting
adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer
- Gemcitabine, Cisplatin, and Bevacizumab in Treating Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00126633 - Active, not recruiting
stage IVA pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
- Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00026104 - Active, not recruiting
stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
- Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00004087 - Active, not recruiting
recurrent colon cancer; recurrent pancreatic cancer; stage IV pancreatic cancer; Stage IV rectal cancer; recurrent rectal cancer; ...
- Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00042939 - Active, not recruiting
adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- INST 0603C Chart Review on Patients With Unresectable/Metastatic Pancreatic Cancer Treated in the UNM Cancer
ClinicalTrials.gov Identifier: NCT00322712 - Active, not recruiting
Pancreatic Cancer
- Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00058201 - Recruiting
acinar cell adenocarcinoma of the pancreas; duct cell adenocarcinoma of the pancreas; stage I pancreatic cancer; stage II pancreatic cancer; ...
- Safety and Efficacy of G17DT Immunogen in the Treatment of Advanced Pancreatic Carcinoma
ClinicalTrials.gov Identifier: NCT00044031 - Active, not recruiting
Pancreatic Cancer
- Study of TNFerade™ Biologic with 5-FU and Radiation Therapy for the Treatment of Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00051467 - Recruiting
Pancreatic Cancer
- Biological Therapy in Treating Patients With Stage I, Stage II, or Stage III Pancreatic Cancer That Has Been Surgically Removed
ClinicalTrials.gov Identifier: NCT00003434 - Active, not recruiting
stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
- Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00112658 - Recruiting
adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00026130 - Active, not recruiting
stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
- Surgery in Treating Patients With Resectable Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00104832 - Recruiting
recurrent pancreatic cancer; stage I pancreatic cancer; stage II pancreatic cancer
- LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer
ClinicalTrials.gov Identifier: NCT00010270 - Active, not recruiting
Colorectal Cancer; Esophageal Cancer; Gastric Cancer; Pancreatic Cancer
- Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00114179 - Active, not recruiting
adenocarcinoma of the pancreas; stage III pancreatic cancer; stage II pancreatic cancer
- Chemotherapy, Interferon alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00068575 - Recruiting
stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
- Gemcitabine With or Without Combination Chemotherapy and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00416507 - Active, not recruiting
Pancreatic Cancer
- Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine
ClinicalTrials.gov Identifier: NCT00397787 - Active, not recruiting
Pancreatic Cancer
- Urine Cadmium Levels in Predicting Pancreatic Cancer Risk in Patients With Chronic Pancreatitis
ClinicalTrials.gov Identifier: NCT00489671 - Active, not recruiting
Pancreatic Cancer; Precancerous/Nonmalignant Condition
- Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00238199 - Active, not recruiting
Pancreatic Cancer
- Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00003798 - Active, not recruiting
stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
- Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00307723 - Recruiting
Pancreatic Cancer; Pancreatic Ductal Adenocarcinoma
- Laparoscopic Ultrasound in Diagnosing Patients With Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00003085 - Active, not recruiting
stage I pancreatic cancer; stage II pancreatic cancer
- Z-360 in Unresectable Advanced Pancreatic Cancer in Combination With Gemcitabine Treatment
ClinicalTrials.gov Identifier: NCT00288925 - Active, not recruiting
Pancreatic Cancer
- PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer after Failing a Gemcitabine-Containing Regimen
ClinicalTrials.gov Identifier: NCT00088660 - Active, not recruiting
Pancreatic Cancer
- Biological Therapy in Treating Patients With Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00004604 - Active, not recruiting
Lung Cancer; Testicular Cancer; ovarian epithelial cancer; Pancreatic Cancer; Colon Cancer; Thyroid Cancer; Gastric Cancer; Salivary Gland Cancer; ...
- Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00176813 - Active, not recruiting
Pancreatic Cancer
- Celecoxib, Irinotecan and Concurrent Radiotherapy in Preoperative Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00177853 - Active, not recruiting
Pancreatic Cancer
- S-1 as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00227604 - Active, not recruiting
Pancreatic Cancer
- Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00268411 - Active, not recruiting
Pancreatic Cancer
- Oxaliplatin, Gemcitabine, Erlotinib, and Radiation Therapy in Treating Patients With Unresectable and/or Metastatic Pancreatic Cancer or Biliary Tract Cancer
ClinicalTrials.gov Identifier: NCT00266097 - Recruiting
Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Pancreatic Cancer
- Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00113256 - Recruiting
Pancreatic Cancer
- Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00192712 - Active, not recruiting
Pancreatic Cancer
- Cyberknife Radiosurgery for Locally Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00233415 - Active, not recruiting
Pancreatic Cancer
- A Phase II Study of Locally Advanced Pancreatic Cancer.
ClinicalTrials.gov Identifier: NCT00149578 - Recruiting
Pancreatic Cancer
- Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the Pancreas
ClinicalTrials.gov Identifier: NCT00020345 - Active, not recruiting
Stage IVA Pancreatic Cancer; Stage III Pancreatic Cancer; Adenocarcinoma of the Pancreas
- Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00275119 - Active, not recruiting
Pancreatic Cancer
- Gene Therapy in Treating Patients With Cancer
ClinicalTrials.gov Identifier: NCT00004178 - Active, not recruiting
Lung Cancer; Pancreatic Cancer; Gastric Cancer; Salivary Gland Cancer; Renal Cell Cancer; Endometrial Cancer; Esophageal Cancer; Head and Neck Cancer; ...
email this page
print this page
bookmark this page
feedback on this page
